Joint Action cover image

Can a blood test predict the risk of osteoarthritis? A discussion with Dr Virginia Kraus

Joint Action

00:00

Advancements in Osteoarthritis Treatment Through Immunomodulation

This chapter explores new developments in disease-modifying drugs targeting the immune and inflammatory aspects of osteoarthritis. It emphasizes a significant trial of an interleukin-1 inhibitor that revealed unexpected benefits in reducing the need for joint replacements.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app